Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of Effective Regulation for the Chinese Genetic Testing Industry.

Trends in biotechnology - 1 Jun 2020

Liu Xiaoqin, Jiang Linzhe, Wang Hongyan, Jiang Chunyang

Abstract excerpt

The genetic testing industry is progressing rapidly. In particular, the demand of patients with tumors for diagnosis, treatment, and testing drives genetic testing to develop further. Simultaneously, the potential risks of genetic testing cause severe challenges to regulatory departments. In China, a targeted, clear, and unified management model remains absent.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to Genetic Diseases, Inborn
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Risk Factors

Source

Identifiers

PMID: 32407687
DOI: 10.1016/j.tibtech.2020.01.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of Effective Regulation for the Chinese Genetic Testing Industry.PMID 32407687Read ↗

Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China.Semantic proximity Read ↗

Precision cancer genome testing needs proficiency testing involving all stakeholders.Semantic proximity Read ↗

Regulatory framework of human germline and heritable genome editing in China: a comparison with the United States and the United KingdomSemantic proximity Read ↗

A national-wide survey on clinical implementation of pharmacogenetic testing into precision therapeutics for Chinese children: A long way before standard clinical practiceSemantic proximity Read ↗

A profile of genetic counseling and testing in Chinese patients with gynecologic oncology: a nationwide survey of Chinese gynecologistsSemantic proximity Read ↗

A primer on regulation of laboratory-developed testing procedures: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Physicians' opinion for ‘new’ genetic testing in JapanSemantic proximity Read ↗

[Establishment of the germline genetic testing system in the laboratory medicine].Semantic proximity Read ↗

Cancer Risk Prediction Regulation Models: Canada Contrasted with the U.S. and the E.U.Semantic proximity Read ↗

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic TestingSemantic proximity Read ↗

Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China.Semantic proximity Read ↗

Responsible governance of human germline genome editing in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.